The partnership integrates high-resolution multi-omics data generation with predictive multimodal machine learning to support biopharma decision-making in neurology.
Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a ...
Efficacy of third-line and later (3L+) therapies post poly (ADP-ribose) polymerase inhibitor (PARPi) exposure in recurrent platinum-sensitive ovarian cancer (PSOC): A pooled clinical trial database ...
Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly one-third of patients and accounting for a major share of cancer-related ...
Heng et al. apply a multi-omics approach combining analyses of energy metabolism, immune cell composition, and plasma proteomics. They reveal altered energy metabolism and immune profiles, alongside ...
Vizgen, Inc., a leader in spatial multi-omics at single-cell resolution, today announced a series of innovations under development to help accelerate drug discovery, advance understanding of disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results